- Home
- RIGL vs API Comparison
RIGL vs API Comparison
Compare RIGL & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- API
- Stock Information
- Founded
- RIGL 1996
- API 2013
- Country
- RIGL United States
- API United States
- Employees
- RIGL N/A
- API N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- RIGL Health Care
- API Technology
- Exchange
- RIGL Nasdaq
- API Nasdaq
- Market Cap
- RIGL 335.5M
- API 343.2M
- IPO Year
- RIGL 2000
- API 2020
- Fundamental
- Price
- RIGL $38.85
- API $3.45
- Analyst Decision
- RIGL Buy
- API Strong Buy
- Analyst Count
- RIGL 5
- API 1
- Target Price
- RIGL $38.20
- API $6.00
- AVG Volume (30 Days)
- RIGL 995.6K
- API 508.9K
- Earning Date
- RIGL 08-05-2025
- API 08-18-2025
- Dividend Yield
- RIGL N/A
- API N/A
- EPS Growth
- RIGL N/A
- API N/A
- EPS
- RIGL 5.43
- API N/A
- Revenue
- RIGL $267,921,000.00
- API $133,554,000.00
- Revenue This Year
- RIGL $59.93
- API $7.20
- Revenue Next Year
- RIGL N/A
- API $11.26
- P/E Ratio
- RIGL $7.15
- API N/A
- Revenue Growth
- RIGL 105.62
- API N/A
- 52 Week Low
- RIGL $12.66
- API $1.78
- 52 Week High
- RIGL $43.72
- API $6.99
- Technical
- Relative Strength Index (RSI)
- RIGL 68.57
- API 40.21
- Support Level
- RIGL $39.00
- API $3.48
- Resistance Level
- RIGL $42.08
- API $3.67
- Average True Range (ATR)
- RIGL 2.32
- API 0.19
- MACD
- RIGL -0.37
- API -0.02
- Stochastic Oscillator
- RIGL 53.26
- API 10.17
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.